Description
An inhibitor of SK1 and SK2 (Kis = 27 and 6.9 μM, respectively); selective for SK1/2 over a panel of 140 human protein kinases at concentrations up to 25 μM; reduces generation of cellular S1P without inducing SK1 degradation in Jurkat cells; induces a 3.7-, 3.5-, and 5.8-fold increase in C-18 ceramide, C-20 ceramide, and C20:1-ceramide levels, respectively; reduces proliferation of a variety of human cancer cell lines (EC50s = 8-44.9 μM); reduces tumor vasculature and volume as well as S1P protein levels in A549 human lung adenocarcinoma xenografts in mice,
Formal name: 4-methyl-N-[2-[[[2-[[(4-methylphenyl)sulfonyl]amino]phenyl]imino]methyl]phenyl]-benzenesulfonamide
Synonyms: NSC 122314
Molecular weight: 519.6
CAS: 219832-49-2
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|Other Lipid Kinases||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Angiogenesis||Research Area|Cancer|Cell Signaling|JNK Signaling||Research Area|Cancer|Cell Signaling|p38 MAPK Signaling||Research Area|Cell Biology|Cell Death|Apoptosis